Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
Abstract Background Alternative RNA splicing is widely dysregulated in cancers including lung adenocarcinoma, where aberrant splicing events are frequently caused by somatic splice site mutations or somatic mutations of splicing factor genes. However, the majority of mis-splicing in cancers is unexp...
Main Authors: | April Lo, Maria McSharry, Alice H. Berger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-10311-1 |
Similar Items
-
The role of KRAS splice variants in cancer biology
by: Cristina Nuevo-Tapioles, et al.
Published: (2022-11-01) -
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
by: Weronika Wojtyś, et al.
Published: (2023-05-01) -
RNA splicing alterations in lung cancer pathogenesis and therapy
by: Yueren Yan, et al.
Published: (2023-10-01) -
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
by: Ya-Sian Chang, et al.
Published: (2020-10-01) -
Phosphorylation mediated regulation of RNA splicing in plants
by: Maria Camila Rodriguez Gallo, et al.
Published: (2023-09-01)